Insider Trading Activity - Versant Venture Capital VI, L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Versant Venture Capital VI, L.P.

Goto Prev, 0, 1

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2020-11-13 Sale	2020-11-17 7:33 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	4,700	$33.74	$158,587	7,781,576 (Indirect Direct)	View
2020-11-12 Sale	2020-11-13 7:47 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	15,598	$34.15	$532,642	6,937,033 (Indirect Direct)	View
2020-11-10 Sale	2020-11-12 5:41 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	39,583	$34.11	$1,350,354	8,751,874 (Indirect Direct)	View
2020-11-06 Sale	2020-11-10 7:24 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	9,400	$33.08	$310,949	8,791,457 (Indirect Direct)	View
2020-11-04 Sale	2020-11-06 4:44 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	11,348	$33.14	$376,127	8,800,857 (Indirect Direct)	View
2020-10-26 Sale	2020-10-28 5:58 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	8,903	$33.28	$296,293	8,812,205 (Indirect Direct)	View
2020-10-15 Sale	2020-10-20 8:09 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	15,746	$33.44	$526,529	8,821,108 (Indirect Direct)	View
2020-10-20 Purchase	2020-10-20 4:58 pm	Aligos Therapeutics Inc.	ALGS	Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner	200,000	$15	$3,000,000	3,292,339 (Indirect Direct)	View
2020-10-13 Sale	2020-10-15 7:22 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	17,240	$33.3	$574,015	8,836,854 (Indirect Direct)	View
2020-10-08 Sale	2020-10-13 7:41 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	22,625	$33.5	$757,924	8,854,094 (Indirect Direct)	View
2020-10-06 Sale	2020-10-08 7:14 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	45,926	$33.44	$1,535,732	6,056,892 (Indirect Direct)	View
2020-08-10 Sale	2020-08-12 7:57 pm	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	13,792	$33.06	$455,989	10,541,469 (Indirect Direct)	View
2020-06-23 Purchase	2020-06-25 6:46 pm	Repare Therapeutics Inc.	RPTX	Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner	250,000	$20	$5,000,000	3,419,451 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2020-11-11 Other	2020-11-13 7:47 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	984,298	$0	6,937,033 (Direct)	View
2020-10-20 Conversion	2020-10-20 4:58 pm	N/A N/A	Aligos Therapeutics Inc.	ALGS	Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner	3,092,339	$0	3,292,339 (Direct)	View
Ownership	2020-10-15 5:16 pm	N/A N/A	Aligos Therapeutics Inc.	ALGS	Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner	0	$0	3,092,339 (Direct)	View
2020-10-07 Other	2020-10-08 7:14 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	299,051	$0	6,056,892 (Indirect)	View
2020-09-17 Other	2020-09-21 7:28 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	754,743	$0	6,569,238 (Direct)	View
2020-08-18 Other	2020-08-20 6:13 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	311,176	$0	10,263,821 (Direct)	View
2020-08-12 Other	2020-08-14 5:55 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	311,176	$0	10,563,821 (Direct)	View
2020-07-27 Other	2020-07-29 9:56 pm	N/A N/A	Black Diamond Therapeutics Inc.	BDTX	Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner	339,843	$0	7,151,621 (Indirect)	View
2020-07-21 Conversion	2020-07-21 7:41 pm	N/A N/A	Pandion Therapeutics Inc.	PAND	Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	21,530,967	$0	3,754,051 (Direct)	View
Ownership	2020-07-16 8:38 pm	N/A N/A	Pandion Therapeutics Inc.	PAND	Versant Venture Capital VI L.P. Versant Vantage I L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner	0	$0	3,754,051 (Direct)	View
2020-06-23 Conversion	2020-06-25 6:46 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner	6,245,349	$0	3,419,451 (Indirect)	View
Ownership	2020-06-18 9:44 pm	N/A N/A	Repare Therapeutics Inc.	RPTX	Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Venture Capital V L.P. Versant Ventures V (Canada) L.P. Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner	0	$0	6,987,679 (Indirect)	View

Goto Prev, 0, 1

Insider Trading & Ownership - Versant Venture Capital VI, L.P.